Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mor

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantationE Mor, B R Meyers, O Yagmur, et al.
Transplantation|December 1, 1993
Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantationE Mor, M E Schwartz, P A Sheiner, et al.
Transplantation Proceedings|March 20, 2003
Cholestasis and hypoalbuminemia as predictors of outcome after liver transplantationE Mor, M Brown, R Michowiz, et al.
Transplantation Proceedings|December 1, 1996
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantationA Yussim, E Shaharabani, E Mor, et al.
Transplantation Proceedings|September 7, 2001
Short intensive care unit stay reduces septic complications and improves outcome after liver transplantationE Mor, J Cohen, E Erez, et al.
Transplantation|September 27, 1995
Backtable resection of a giant cavernous hemangioma in a donor liverE Mor, P Boccagni, S N Thung, et al.
Harefuah|May 15, 1997
[Liver allografts from donors older than 60: benefits and risks]E Mor, D Shmueli, Z Ben-Ari, et al.
Clinical Transplants|January 1, 1994
Liver transplantation at Mount Sinai HospitalE Mor, P A Sheiner, M E Schwartz, et al.
Transplantation|May 15, 1994
Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506R M Jindal, I Popescu, S Emre, et al.
Transplantation|June 15, 1995
FK506 hepatotoxicity in liver allograft recipientsA Fisher, E Mor, P Hytiroglou, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantationE Mor, B R Meyers, O Yagmur, et al.
Transplantation|December 1, 1993
Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantationE Mor, M E Schwartz, P A Sheiner, et al.
Transplantation Proceedings|March 20, 2003
Cholestasis and hypoalbuminemia as predictors of outcome after liver transplantationE Mor, M Brown, R Michowiz, et al.
Transplantation Proceedings|December 1, 1996
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantationA Yussim, E Shaharabani, E Mor, et al.
Transplantation Proceedings|September 7, 2001
Short intensive care unit stay reduces septic complications and improves outcome after liver transplantationE Mor, J Cohen, E Erez, et al.
Transplantation|September 27, 1995
Backtable resection of a giant cavernous hemangioma in a donor liverE Mor, P Boccagni, S N Thung, et al.
Harefuah|May 15, 1997
[Liver allografts from donors older than 60: benefits and risks]E Mor, D Shmueli, Z Ben-Ari, et al.
Clinical Transplants|January 1, 1994
Liver transplantation at Mount Sinai HospitalE Mor, P A Sheiner, M E Schwartz, et al.
Transplantation|May 15, 1994
Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506R M Jindal, I Popescu, S Emre, et al.
Transplantation|June 15, 1995
FK506 hepatotoxicity in liver allograft recipientsA Fisher, E Mor, P Hytiroglou, et al.
Pageof 17